Invention Grant
- Patent Title: Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
- Patent Title (中): 用于口服施用唑来膦酸或相关化合物治疗疾病的剂型
-
Application No.: US14279196Application Date: 2014-05-15
-
Publication No.: US09301964B2Publication Date: 2016-04-05
- Inventor: Herriot Tabuteau
- Applicant: Antecip Bioventures II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Brent A. Johnson
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/663 ; A61K9/20 ; A61K9/00 ; A61K9/28
Abstract:
Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
Public/Granted literature
- US20140249107A1 DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE Public/Granted day:2014-09-04
Information query
